Biochemical "defect" in the hypertrophied and failing heart: deleterious or compensatory?
D000251:Adenosine Triphosphatases / Q000378:metabolism; D000255:Adenosine Triphosphate / Q000378:metabolism; D000818:Animals; D002118:Calcium / Q000378:metabolism; D006332:Cardiomegaly / Q000378:metabolism*; D003327:Coronary Disease / Q000188:drug therapy; D004071:Digitalis Glycosides / Q000627:therapeutic use; D006333:Heart Failure / Q000188:drug therapy / Q000378:metabolism*; D006439:Hemodynamics; D006801:Humans; D009206:Myocardium / Q000378:metabolism*; D009218:Myosins / Q000378:metabolism; D009336:Necrosis; D009638:Norepinephrine / Q000378:metabolism; D010101:Oxygen Consumption; D010725:Phosphocreatine / Q000378:metabolism; D011433:Propranolol / Q000009:adverse effects / Q000627:therapeutic use
D004071:Digitalis Glycosides; D010725:Phosphocreatine; D000255:Adenosine Triphosphate; D011433:Propranolol; D000251:Adenosine Triphosphatases; D009218:Myosins; D002118:Calcium; D009638:Norepinephrine